Cargando…
Cardiac glycoside/aglycones inhibit HIV-1 gene expression by a mechanism requiring MEK1/2-ERK1/2 signaling
The capacity of HIV-1 to develop resistance to current drugs calls for innovative strategies to control this infection. We aimed at developing novel inhibitors of HIV-1 replication by targeting viral RNA processing—a stage dependent on conserved host processes. We previously reported that digoxin is...
Autores principales: | Wong, Raymond W., Lingwood, Clifford A., Ostrowski, Mario A., Cabral, Tyler, Cochrane, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770468/ https://www.ncbi.nlm.nih.gov/pubmed/29339801 http://dx.doi.org/10.1038/s41598-018-19298-x |
Ejemplares similares
-
Author Correction: Cardiac glycoside/aglycones inhibit HIV-1 gene expression by a mechanism requiring MEK1/2-ERK1/2 signaling
por: Wong, Raymond W., et al.
Publicado: (2019) -
An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing
por: Wong, Raymond W., et al.
Publicado: (2020) -
Molecular Mechanisms Underlying the Absorption of
Aglycone and Glycosidic Flavonoids in a Caco-2 BBe1 Cell Model
por: Zhang, Hua, et al.
Publicado: (2020) -
Comparison of Flavonoid O-Glycoside, C-Glycoside and Their Aglycones on Antioxidant Capacity and Metabolism during In Vitro Digestion and In Vivo
por: Xie, Liangqin, et al.
Publicado: (2022) -
Digoxin Suppresses HIV-1 Replication by Altering Viral RNA Processing
por: Wong, Raymond W., et al.
Publicado: (2013)